Use of Hydromorphone, with Particular Reference to the OROS® Formulation, in the Elderly

ISSN： 1170-229X

Source： Drugs & Aging, Vol.27, Iss.4, 2010-04, pp. : 327-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hydromorphone-OROS formulation

By Goforth Harold W

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1207-1214

Informa Healthcare

Access to resources Recommend Favorite

OROS hydromorphone of value for osteoarthritis pain

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

OROS® Hydromorphone Prolonged Release: A Review of its Use in the Management of Chronic, Moderate to Severe Pain

By Carter Natalie J. Keating Gillian M.

CNS Drugs, Vol. 24, Iss. 4, 2010-04 ,pp. : 337-361

Adis International

Access to resources Recommend Favorite

Chronic conditions no longer a pain with OROS hydromorphone

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 504, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

OROS hydromorphone vs ER oxycodone: a close call in OA

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite